State Of Wyoming Adverum Biotechnologies, Inc. Transaction History

State Of Wyoming

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $25,011 - $41,376	-30,878 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.23 - $1.95 $19,608 - $31,086	15,942 Added 106.74%	30,878 $40,000
Q4 2021 Feb 11, 2022	BUY	$1.74 - $2.4 $25,988 - $35,846	14,936 New	14,936 $26,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $522M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.